Clive Morris

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.

Wheatsheaf Investments Ltd (Wheatsheaf Investments) is a venture capital subsidiary of Grosvenor Group Ltd. founded in 2012. The firm is headquartered in London, United Kingdom with an additional office in Palo Alto.